MINNODERM 2% SOLUTION (Each bottle contains Minoxidil 20mg
Minoxidil
What it does
Minoxidil is a medication used to promote hair growth in people with certain types of hair loss.
Commonly used for: hair loss (androgenetic alopecia), baldness
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Food and Drugs Authority · fetched 2026-09-01 04:00:29 · updated 2026-09-18 04:00:05
About this medicine
Minoxidil is a medication used to promote hair growth in people with certain types of hair loss.
What it treats
- hair loss (androgenetic alopecia)
- baldness
How it works
Minoxidil works by increasing blood flow to the hair follicles, which helps stimulate hair growth.
Who it's for
Minoxidil is for adults experiencing hair thinning or baldness.
Cautions
- • Avoid using with other medications that lower blood pressure.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Minoxidil
BNF-referencedMinoxidil is a potent vasodilator primarily used for the treatment of androgenetic alopecia (male and female pattern hair loss) and hypertension. It acts by relaxing the smooth muscle in blood vessels, leading to vasodilation and increased blood flow. Topical formulations are applied to the scalp for hair regrowth, while oral forms are used in severe cases of hypertension.
Indications
- Androgenetic alopecia
- Severe hypertension
Dosage
Children: For children, application for scalp conditions should be as required, but specific dosing guidelines for minoxidil in children should be referred to in the BNF for Children.
Adults: For androgenetic alopecia, apply 1 mL to the affected areas of the scalp twice daily. For hypertension, refer to specific dosing guidelines in the BNF.
Mechanism of action
Minoxidil acts as a potassium channel opener, which leads to hyperpolarization of the cell membrane and relaxation of vascular smooth muscle. This results in vasodilation and a decrease in blood pressure. The precise mechanism for its hair growth promoting effects is not fully understood, but it is believed to enhance hair follicle size and prolong the anagen phase of hair growth.
Pharmacodynamics
Minoxidil’s vasodilatory effects lead to a reduction in peripheral vascular resistance and lower blood pressure. For hair growth, the drug appears to increase the size of hair follicles, improve blood flow to the scalp, and stimulate hair follicle cells. These effects contribute to visible improvements in hair density and thickness in patients with androgenetic alopecia.
Pharmacokinetics
Minoxidil is well-absorbed when applied topically, with a bioavailability of approximately 1.5% to 3% for the scalp application. After absorption, minoxidil is extensively metabolized in the liver, primarily to its active sulfate form. It has a half-life of about 4.2 hours and is primarily excreted in the urine. Its effects on blood pressure and hair growth are dose-dependent.
Contra-indications
- History of hypersensitivity to minoxidil or any of the excipients
- Use in patients with pheochromocytoma
- Use in patients with a history of angioedema
Adverse effects
- Hypertrichosis
- Headache
- Dizziness
- Edema
- Tachycardia
- Palpitations
- Skin irritation
- Flushing
- Chest pain
Interactions
- Caution when used with other antihypertensive agents as it may potentiate their effects
- Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect
- Use with caution in combination with vasodilators
Precautions
- Monitor patients for signs of fluid retention and adjust dosage accordingly
- Use with caution in patients with cardiovascular disease
- Discontinue if unexpected weight gain or peripheral edema occurs
- Avoid use in patients with renal impairment
Pregnancy
Manufacturer advises avoiding use during pregnancy due to potential risk to the fetus.
Breast-feeding
Minoxidil is excreted in breast milk; manufacturer advises avoiding use during breastfeeding.
Storage
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Formulations
- Topical solution: 2% and 5% concentrations for scalp application
- Topical foam: 5% concentration for scalp application
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Minoxidil
PubChem CID 4201Molecular formula: C9H15N5O
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.